Article
Author(s):
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Early Trial Success Signals Promise for GT-02287 in Parkinson’s Disease Treatment
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
Pharma Industry Execs React to President Trump’s 60-Day MFN Deadline
Beyond the Prescription: Pharma's Role in Digital Health Conversations
Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027
FDA Approves Label Update for Novartis’ Leqvio to Enable Twice-Yearly Monotherapy for LDL-C Management in Adults with Hypercholesterolemia